Legal & General Group Plc Acquires 201 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Legal & General Group Plc boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.0% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 20,701 shares of the company’s stock after buying an additional 201 shares during the period. Legal & General Group Plc owned approximately 0.17% of U.S. Physical Therapy worth $1,352,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Legato Capital Management LLC boosted its stake in shares of U.S. Physical Therapy by 6,430.0% in the first quarter. Legato Capital Management LLC now owns 95,534 shares of the company’s stock valued at $1,463,000 after buying an additional 94,071 shares in the last quarter. Aberdeen Asset Management PLC UK boosted its stake in shares of U.S. Physical Therapy by 11.0% in the first quarter. Aberdeen Asset Management PLC UK now owns 621,754 shares of the company’s stock valued at $40,601,000 after buying an additional 61,715 shares in the last quarter. State Street Corp boosted its stake in shares of U.S. Physical Therapy by 10.2% in the fourth quarter. State Street Corp now owns 297,114 shares of the company’s stock valued at $20,851,000 after buying an additional 27,511 shares in the last quarter. Oxford Asset Management bought a new stake in shares of U.S. Physical Therapy during the first quarter valued at about $1,321,000. Finally, Scout Investments Inc. boosted its stake in shares of U.S. Physical Therapy by 20.6% in the first quarter. Scout Investments Inc. now owns 89,470 shares of the company’s stock valued at $4,449,000 after buying an additional 15,275 shares in the last quarter. Hedge funds and other institutional investors own 95.73% of the company’s stock.

U.S. Physical Therapy, Inc. (USPH) traded up 0.94% on Friday, reaching $59.25. 205,539 shares of the company’s stock traded hands. The stock has a market cap of $745.42 million, a price-to-earnings ratio of 37.50 and a beta of 1.06. The stock has a 50 day moving average price of $62.30 and a 200 day moving average price of $65.75. U.S. Physical Therapy, Inc. has a 12-month low of $51.96 and a 12-month high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. The firm had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million. Analysts forecast that U.S. Physical Therapy, Inc. will post $2.13 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 8th. Shareholders of record on Monday, August 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 17th. U.S. Physical Therapy’s dividend payout ratio is presently 46.78%.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by BNB Daily and is owned by of BNB Daily. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.baseball-news-blog.com/2017/08/19/legal-general-group-plc-increases-position-in-u-s-physical-therapy-inc-nyseusph-updated-updated-updated.html.

Several equities research analysts recently issued reports on USPH shares. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Saturday, April 22nd. Jefferies Group LLC restated a “hold” rating and issued a $63.00 target price on shares of U.S. Physical Therapy in a report on Friday, June 30th. Barrington Research upgraded shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target on the stock in a research report on Monday, July 3rd. BidaskClub downgraded shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. Finally, Cantor Fitzgerald initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They issued an “overweight” rating and a $72.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. U.S. Physical Therapy currently has a consensus rating of “Hold” and a consensus price target of $68.50.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 3,000 shares of the company’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $62.04, for a total transaction of $186,120.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bernard A. Harris, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $62.00, for a total transaction of $310,000.00. Following the transaction, the director now owns 26,422 shares of the company’s stock, valued at $1,638,164. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply